Global Primary Immunodeficiency Therapeutic Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Primary Immunodeficiency Therapeutic Market Size 2017-2028

2.1.2 Primary Immunodeficiency Therapeutic Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Primary Immunodeficiency Therapeutic Segment by Type

2.2.1 Immunoglobulin Replacement Therapy

2.2.2 Stem Cell or Bone Marrow Transplantation

2.2.3 Antibiotic Therapy

2.2.4 Gene Therapy

2.2.5 Others

2.3 Primary Immunodeficiency Therapeutic Market Size by Type

2.3.1 Primary Immunodeficiency Therapeutic Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Primary Immunodeficiency Therapeutic Market Size Market Share by Type (2017-2022)

2.4 Primary Immunodeficiency Therapeutic Segment by Application

2.4.1 Antibody Deficiency

2.4.2 Cellular Immunodeficiency

2.4.3 Innate Immune Disorders

2.4.4 Others

2.5 Primary Immunodeficiency Therapeutic Market Size by Application

2.5.1 Primary Immunodeficiency Therapeutic Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Primary Immunodeficiency Therapeutic Market Size Market Share by Application (2017-2022)

3 Primary Immunodeficiency Therapeutic Market Size by Player

3.1 Primary Immunodeficiency Therapeutic Market Size Market Share by Players

3.1.1 Global Primary Immunodeficiency Therapeutic Revenue by Players (2020-2022)

3.1.2 Global Primary Immunodeficiency Therapeutic Revenue Market Share by Players (2020-2022)

3.2 Global Primary Immunodeficiency Therapeutic Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Primary Immunodeficiency Therapeutic by Regions

4.1 Primary Immunodeficiency Therapeutic Market Size by Regions (2017-2022)

4.2 Americas Primary Immunodeficiency Therapeutic Market Size Growth (2017-2022)

4.3 APAC Primary Immunodeficiency Therapeutic Market Size Growth (2017-2022)

4.4 Europe Primary Immunodeficiency Therapeutic Market Size Growth (2017-2022)

4.5 Middle East & Africa Primary Immunodeficiency Therapeutic Market Size Growth (2017-2022)

5 Americas

5.1 Americas Primary Immunodeficiency Therapeutic Market Size by Country (2017-2022)

5.2 Americas Primary Immunodeficiency Therapeutic Market Size by Type (2017-2022)

5.3 Americas Primary Immunodeficiency Therapeutic Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Primary Immunodeficiency Therapeutic Market Size by Region (2017-2022)

6.2 APAC Primary Immunodeficiency Therapeutic Market Size by Type (2017-2022)

6.3 APAC Primary Immunodeficiency Therapeutic Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Primary Immunodeficiency Therapeutic by Country (2017-2022)

7.2 Europe Primary Immunodeficiency Therapeutic Market Size by Type (2017-2022)

7.3 Europe Primary Immunodeficiency Therapeutic Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Primary Immunodeficiency Therapeutic by Region (2017-2022)

8.2 Middle East & Africa Primary Immunodeficiency Therapeutic Market Size by Type (2017-2022)

8.3 Middle East & Africa Primary Immunodeficiency Therapeutic Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Primary Immunodeficiency Therapeutic Market Forecast

10.1 Global Primary Immunodeficiency Therapeutic Forecast by Regions (2023-2028)

10.1.1 Global Primary Immunodeficiency Therapeutic Forecast by Regions (2023-2028)

10.1.2 Americas Primary Immunodeficiency Therapeutic Forecast

10.1.3 APAC Primary Immunodeficiency Therapeutic Forecast

10.1.4 Europe Primary Immunodeficiency Therapeutic Forecast

10.1.5 Middle East & Africa Primary Immunodeficiency Therapeutic Forecast

10.2 Americas Primary Immunodeficiency Therapeutic Forecast by Country (2023-2028)

10.2.1 United States Primary Immunodeficiency Therapeutic Market Forecast

10.2.2 Canada Primary Immunodeficiency Therapeutic Market Forecast

10.2.3 Mexico Primary Immunodeficiency Therapeutic Market Forecast

10.2.4 Brazil Primary Immunodeficiency Therapeutic Market Forecast

10.3 APAC Primary Immunodeficiency Therapeutic Forecast by Region (2023-2028)

10.3.1 China Primary Immunodeficiency Therapeutic Market Forecast

10.3.2 Japan Primary Immunodeficiency Therapeutic Market Forecast

10.3.3 Korea Primary Immunodeficiency Therapeutic Market Forecast

10.3.4 Southeast Asia Primary Immunodeficiency Therapeutic Market Forecast

10.3.5 India Primary Immunodeficiency Therapeutic Market Forecast

10.3.6 Australia Primary Immunodeficiency Therapeutic Market Forecast

10.4 Europe Primary Immunodeficiency Therapeutic Forecast by Country (2023-2028)

10.4.1 Germany Primary Immunodeficiency Therapeutic Market Forecast

10.4.2 France Primary Immunodeficiency Therapeutic Market Forecast

10.4.3 UK Primary Immunodeficiency Therapeutic Market Forecast

10.4.4 Italy Primary Immunodeficiency Therapeutic Market Forecast

10.4.5 Russia Primary Immunodeficiency Therapeutic Market Forecast

10.5 Middle East & Africa Primary Immunodeficiency Therapeutic Forecast by Region (2023-2028)

10.5.1 Egypt Primary Immunodeficiency Therapeutic Market Forecast

10.5.2 South Africa Primary Immunodeficiency Therapeutic Market Forecast

10.5.3 Israel Primary Immunodeficiency Therapeutic Market Forecast

10.5.4 Turkey Primary Immunodeficiency Therapeutic Market Forecast

10.5.5 GCC Countries Primary Immunodeficiency Therapeutic Market Forecast

10.6 Global Primary Immunodeficiency Therapeutic Forecast by Type (2023-2028)

10.7 Global Primary Immunodeficiency Therapeutic Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Baxter International

11.1.1 Baxter International Company Information

11.1.2 Baxter International Primary Immunodeficiency Therapeutic Product Offered

11.1.3 Baxter International Primary Immunodeficiency Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Baxter International Main Business Overview

11.1.5 Baxter International Latest Developments

11.2 Takeda Pharmaceutical

11.2.1 Takeda Pharmaceutical Company Information

11.2.2 Takeda Pharmaceutical Primary Immunodeficiency Therapeutic Product Offered

11.2.3 Takeda Pharmaceutical Primary Immunodeficiency Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Takeda Pharmaceutical Main Business Overview

11.2.5 Takeda Pharmaceutical Latest Developments

11.3 CSL Limited

11.3.1 CSL Limited Company Information

11.3.2 CSL Limited Primary Immunodeficiency Therapeutic Product Offered

11.3.3 CSL Limited Primary Immunodeficiency Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 CSL Limited Main Business Overview

11.3.5 CSL Limited Latest Developments

11.4 Octapharma

11.4.1 Octapharma Company Information

11.4.2 Octapharma Primary Immunodeficiency Therapeutic Product Offered

11.4.3 Octapharma Primary Immunodeficiency Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Octapharma Main Business Overview

11.4.5 Octapharma Latest Developments

11.5 Kedrion Biopharma

11.5.1 Kedrion Biopharma Company Information

11.5.2 Kedrion Biopharma Primary Immunodeficiency Therapeutic Product Offered

11.5.3 Kedrion Biopharma Primary Immunodeficiency Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Kedrion Biopharma Main Business Overview

11.5.5 Kedrion Biopharma Latest Developments

11.6 Bio Products Laboratory

11.6.1 Bio Products Laboratory Company Information

11.6.2 Bio Products Laboratory Primary Immunodeficiency Therapeutic Product Offered

11.6.3 Bio Products Laboratory Primary Immunodeficiency Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Bio Products Laboratory Main Business Overview

11.6.5 Bio Products Laboratory Latest Developments

11.7 LFB group

11.7.1 LFB group Company Information

11.7.2 LFB group Primary Immunodeficiency Therapeutic Product Offered

11.7.3 LFB group Primary Immunodeficiency Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 LFB group Main Business Overview

11.7.5 LFB group Latest Developments

11.8 Grifols

11.8.1 Grifols Company Information

11.8.2 Grifols Primary Immunodeficiency Therapeutic Product Offered

11.8.3 Grifols Primary Immunodeficiency Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Grifols Main Business Overview

11.8.5 Grifols Latest Developments

11.9 Lupin Pharmaceuticals

11.9.1 Lupin Pharmaceuticals Company Information

11.9.2 Lupin Pharmaceuticals Primary Immunodeficiency Therapeutic Product Offered

11.9.3 Lupin Pharmaceuticals Primary Immunodeficiency Therapeutic Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Lupin Pharmaceuticals Main Business Overview

11.9.5 Lupin Pharmaceuticals Latest Developments

12 Research Findings and Conclusion

Table 1. Primary Immunodeficiency Therapeutic Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Immunoglobulin Replacement Therapy

Table 3. Major Players of Stem Cell or Bone Marrow Transplantation

Table 4. Major Players of Antibiotic Therapy

Table 5. Major Players of Gene Therapy

Table 6. Major Players of Others

Table 7. Primary Immunodeficiency Therapeutic Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Primary Immunodeficiency Therapeutic Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Primary Immunodeficiency Therapeutic Market Size Market Share by Type (2017-2022)

Table 10. Primary Immunodeficiency Therapeutic Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Primary Immunodeficiency Therapeutic Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Primary Immunodeficiency Therapeutic Market Size Market Share by Application (2017-2022)

Table 13. Global Primary Immunodeficiency Therapeutic Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Primary Immunodeficiency Therapeutic Revenue Market Share by Player (2020-2022)

Table 15. Primary Immunodeficiency Therapeutic Key Players Head office and Products Offered

Table 16. Primary Immunodeficiency Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Primary Immunodeficiency Therapeutic Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Primary Immunodeficiency Therapeutic Market Size Market Share by Regions (2017-2022)

Table 21. Americas Primary Immunodeficiency Therapeutic Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Primary Immunodeficiency Therapeutic Market Size Market Share by Country (2017-2022)

Table 23. Americas Primary Immunodeficiency Therapeutic Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Primary Immunodeficiency Therapeutic Market Size Market Share by Type (2017-2022)

Table 25. Americas Primary Immunodeficiency Therapeutic Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Primary Immunodeficiency Therapeutic Market Size Market Share by Application (2017-2022)

Table 27. APAC Primary Immunodeficiency Therapeutic Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Primary Immunodeficiency Therapeutic Market Size Market Share by Region (2017-2022)

Table 29. APAC Primary Immunodeficiency Therapeutic Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Primary Immunodeficiency Therapeutic Market Size Market Share by Type (2017-2022)

Table 31. APAC Primary Immunodeficiency Therapeutic Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Primary Immunodeficiency Therapeutic Market Size Market Share by Application (2017-2022)

Table 33. Europe Primary Immunodeficiency Therapeutic Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Primary Immunodeficiency Therapeutic Market Size Market Share by Country (2017-2022)

Table 35. Europe Primary Immunodeficiency Therapeutic Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Primary Immunodeficiency Therapeutic Market Size Market Share by Type (2017-2022)

Table 37. Europe Primary Immunodeficiency Therapeutic Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Primary Immunodeficiency Therapeutic Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Primary Immunodeficiency Therapeutic Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Primary Immunodeficiency Therapeutic Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Primary Immunodeficiency Therapeutic Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Primary Immunodeficiency Therapeutic Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Primary Immunodeficiency Therapeutic Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Primary Immunodeficiency Therapeutic Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Primary Immunodeficiency Therapeutic

Table 46. Key Market Challenges & Risks of Primary Immunodeficiency Therapeutic

Table 47. Key Industry Trends of Primary Immunodeficiency Therapeutic

Table 48. Global Primary Immunodeficiency Therapeutic Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Primary Immunodeficiency Therapeutic Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Primary Immunodeficiency Therapeutic Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Primary Immunodeficiency Therapeutic Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Primary Immunodeficiency Therapeutic Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Primary Immunodeficiency Therapeutic Market Size Market Share Forecast by Application (2023-2028)

Table 54. Baxter International Details, Company Type, Primary Immunodeficiency Therapeutic Area Served and Its Competitors

Table 55. Baxter International Primary Immunodeficiency Therapeutic Product Offered

Table 56. Baxter International Primary Immunodeficiency Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. Baxter International Main Business

Table 58. Baxter International Latest Developments

Table 59. Takeda Pharmaceutical Details, Company Type, Primary Immunodeficiency Therapeutic Area Served and Its Competitors

Table 60. Takeda Pharmaceutical Primary Immunodeficiency Therapeutic Product Offered

Table 61. Takeda Pharmaceutical Main Business

Table 62. Takeda Pharmaceutical Primary Immunodeficiency Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. Takeda Pharmaceutical Latest Developments

Table 64. CSL Limited Details, Company Type, Primary Immunodeficiency Therapeutic Area Served and Its Competitors

Table 65. CSL Limited Primary Immunodeficiency Therapeutic Product Offered

Table 66. CSL Limited Main Business

Table 67. CSL Limited Primary Immunodeficiency Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. CSL Limited Latest Developments

Table 69. Octapharma Details, Company Type, Primary Immunodeficiency Therapeutic Area Served and Its Competitors

Table 70. Octapharma Primary Immunodeficiency Therapeutic Product Offered

Table 71. Octapharma Main Business

Table 72. Octapharma Primary Immunodeficiency Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. Octapharma Latest Developments

Table 74. Kedrion Biopharma Details, Company Type, Primary Immunodeficiency Therapeutic Area Served and Its Competitors

Table 75. Kedrion Biopharma Primary Immunodeficiency Therapeutic Product Offered

Table 76. Kedrion Biopharma Main Business

Table 77. Kedrion Biopharma Primary Immunodeficiency Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Kedrion Biopharma Latest Developments

Table 79. Bio Products Laboratory Details, Company Type, Primary Immunodeficiency Therapeutic Area Served and Its Competitors

Table 80. Bio Products Laboratory Primary Immunodeficiency Therapeutic Product Offered

Table 81. Bio Products Laboratory Main Business

Table 82. Bio Products Laboratory Primary Immunodeficiency Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. Bio Products Laboratory Latest Developments

Table 84. LFB group Details, Company Type, Primary Immunodeficiency Therapeutic Area Served and Its Competitors

Table 85. LFB group Primary Immunodeficiency Therapeutic Product Offered

Table 86. LFB group Main Business

Table 87. LFB group Primary Immunodeficiency Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. LFB group Latest Developments

Table 89. Grifols Details, Company Type, Primary Immunodeficiency Therapeutic Area Served and Its Competitors

Table 90. Grifols Primary Immunodeficiency Therapeutic Product Offered

Table 91. Grifols Main Business

Table 92. Grifols Primary Immunodeficiency Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 93. Grifols Latest Developments

Table 94. Lupin Pharmaceuticals Details, Company Type, Primary Immunodeficiency Therapeutic Area Served and Its Competitors

Table 95. Lupin Pharmaceuticals Primary Immunodeficiency Therapeutic Product Offered

Table 96. Lupin Pharmaceuticals Main Business

Table 97. Lupin Pharmaceuticals Primary Immunodeficiency Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 98. Lupin Pharmaceuticals Latest Developments

List of Figures

Figure 1. Primary Immunodeficiency Therapeutic Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Primary Immunodeficiency Therapeutic Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Primary Immunodeficiency Therapeutic Market Size Market Share by Type in 2021

Figure 7. Primary Immunodeficiency Therapeutic in Antibody Deficiency

Figure 8. Global Primary Immunodeficiency Therapeutic Market: Antibody Deficiency (2017-2022) & ($ Millions)

Figure 9. Primary Immunodeficiency Therapeutic in Cellular Immunodeficiency

Figure 10. Global Primary Immunodeficiency Therapeutic Market: Cellular Immunodeficiency (2017-2022) & ($ Millions)

Figure 11. Primary Immunodeficiency Therapeutic in Innate Immune Disorders

Figure 12. Global Primary Immunodeficiency Therapeutic Market: Innate Immune Disorders (2017-2022) & ($ Millions)

Figure 13. Primary Immunodeficiency Therapeutic in Others

Figure 14. Global Primary Immunodeficiency Therapeutic Market: Others (2017-2022) & ($ Millions)

Figure 15. Global Primary Immunodeficiency Therapeutic Market Size Market Share by Application in 2021

Figure 16. Global Primary Immunodeficiency Therapeutic Revenue Market Share by Player in 2021

Figure 17. Global Primary Immunodeficiency Therapeutic Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Primary Immunodeficiency Therapeutic Market Size 2017-2022 ($ Millions)

Figure 19. APAC Primary Immunodeficiency Therapeutic Market Size 2017-2022 ($ Millions)

Figure 20. Europe Primary Immunodeficiency Therapeutic Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Primary Immunodeficiency Therapeutic Market Size 2017-2022 ($ Millions)

Figure 22. Americas Primary Immunodeficiency Therapeutic Value Market Share by Country in 2021

Figure 23. Americas Primary Immunodeficiency Therapeutic Consumption Market Share by Type in 2021

Figure 24. Americas Primary Immunodeficiency Therapeutic Market Size Market Share by Application in 2021

Figure 25. United States Primary Immunodeficiency Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Primary Immunodeficiency Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Primary Immunodeficiency Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Primary Immunodeficiency Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Primary Immunodeficiency Therapeutic Market Size Market Share by Region in 2021

Figure 30. APAC Primary Immunodeficiency Therapeutic Market Size Market Share by Application in 2021

Figure 31. China Primary Immunodeficiency Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Primary Immunodeficiency Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Primary Immunodeficiency Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Primary Immunodeficiency Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Primary Immunodeficiency Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Primary Immunodeficiency Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Primary Immunodeficiency Therapeutic Market Size Market Share by Country in 2021

Figure 38. Europe Primary Immunodeficiency Therapeutic Market Size Market Share by Type in 2021

Figure 39. Europe Primary Immunodeficiency Therapeutic Market Size Market Share by Application in 2021

Figure 40. Germany Primary Immunodeficiency Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Primary Immunodeficiency Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Primary Immunodeficiency Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Primary Immunodeficiency Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Primary Immunodeficiency Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Primary Immunodeficiency Therapeutic Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Primary Immunodeficiency Therapeutic Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Primary Immunodeficiency Therapeutic Market Size Market Share by Application in 2021

Figure 48. Egypt Primary Immunodeficiency Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Primary Immunodeficiency Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Primary Immunodeficiency Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Primary Immunodeficiency Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Primary Immunodeficiency Therapeutic Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 54. APAC Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 55. Europe Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 57. United States Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 58. Canada Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 61. China Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 62. Japan Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 63. Korea Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 65. India Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 66. Australia Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 67. Germany Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 68. France Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 69. UK Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 70. Italy Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 71. Russia Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 72. Spain Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 75. Israel Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Primary Immunodeficiency Therapeutic Market Size 2023-2028 ($ Millions)